Mitchell; Lorna
Patent Applications and Registrations
Patent applications and USPTO patent grants for Mitchell; Lorna.The latest application filed is for "activating pyruvate kinase r".
- Mitchell; Lorna - Cambridge NZ
- Mitchell; Lorna - West Beach AU
- Mitchell; Lorna - Thebarton AU
- Mitchell; Lorna - Christchurch 8061 NZ
- Mitchell, Lorna - Dexter MI
| Patent | Date |
|---|---|
| Activating Pyruvate Kinase R App 20220304987 - Ericsson; Anna ; et al. | 2022-09-29 |
| Compositions for activating pyruvate kinase Grant 11,396,513 - Zheng , et al. July 26, 2 | 2022-07-26 |
| Activating Pyruvate Kinase R App 20220087983 - Ericsson; Anna ; et al. | 2022-03-24 |
| Treating Sickle Cell Disease With A Pyruvate Kinase R Activating Compound App 20220031671 - ERICSSON; Anna ; et al. | 2022-02-03 |
| Cyclic compounds as receptor modulating therapeutics and methods and uses thereof App 20210355124 - Mitchell; Lorna ; et al. | 2021-11-18 |
| Activating Pyruvate Kinase R App 20210308108 - Ericsson; Anna ; et al. | 2021-10-07 |
| Pyrrolopyrrole Compositions As Pyruvate Kinase (pkr) Activators App 20210246143 - ERICSSON; Anna ; et al. | 2021-08-12 |
| Activating pyruvate kinase R Grant 11,071,725 - Ericsson , et al. July 27, 2 | 2021-07-27 |
| Activating Pyruvate Kinase R And Mutants Thereof App 20210221816 - Lancia, JR.; David R. ; et al. | 2021-07-22 |
| Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators Grant 11,014,927 - Ericsson , et al. May 25, 2 | 2021-05-25 |
| Activating pyruvate kinase R and mutants thereof Grant 11,001,588 - Lancia, Jr. , et al. May 11, 2 | 2021-05-11 |
| Compositions For Activating Pyruvate Kinase App 20210017184 - Zheng; Xiaozhang ; et al. | 2021-01-21 |
| Treating Sickle Cell Disease With A Pyruvate Kinase R Activating Compound App 20200405699 - ERICSSON; Anna ; et al. | 2020-12-31 |
| Compositions for activating pyruvate kinase Grant 10,836,771 - Zheng , et al. November 17, 2 | 2020-11-17 |
| Activating Pyruvate Kinase R App 20200253939 - Kind Code | 2020-08-13 |
| Activating pyruvate kinase R Grant 10,675,274 - Ericsson , et al. | 2020-06-09 |
| Treating Sickle Cell Disease With A Pyruvate Kinase R Activating Compound App 20200129485 - Ericsson; Anna ; et al. | 2020-04-30 |
| Activating Pyruvate Kinase R And Mutants Thereof App 20200087309 - Lancia, JR.; David R. ; et al. | 2020-03-19 |
| Activating Pyruvate Kinase R App 20200085798 - Ericsson; Anna ; et al. | 2020-03-19 |
| Pyrrolopyrrole Compositions As Pyruvate Kinase (pkr) Activators App 20200069643 - ERICSSON; Anna ; et al. | 2020-03-05 |
| Compositions For Activating Pyruvate Kinase App 20200031839 - Zheng; Xiaozhang ; et al. | 2020-01-30 |
| Compositions for activating pyruvate kinase Grant 10,472,371 - Zheng , et al. Nov | 2019-11-12 |
| Compositions For Activating Pyruvate Kinase App 20190218221 - Zheng; Xiaozhang ; et al. | 2019-07-18 |
| Compositions for activating pyruvate kinase Grant 10,208,052 - Zheng , et al. Feb | 2019-02-19 |
| Clematis plant named `RobloM` Grant PP21,203 - Mitchell , et al. August 17, 2 | 2010-08-17 |
| [B]-fused bicyclic proline derivatives and their use for treating arthritic conditions App 20050143427 - Barvian, Nicole C. ; et al. | 2005-06-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 